Literature DB >> 11714071

Case report. Successfully treated subcutaneous infection with Sporothrix schenckii in Turkey.

A N Koç, U Ukşal, O Oymak.   

Abstract

Sporotrichosis is rare in Turkey. We report a 48-year-old man who had subcutaneous sporotrichosis caused by Sporothrix schenckii that was successfully treated with short-term itraconazole and potassium iodide. The isolate was susceptible to itraconazole also in vitro. Short-term itraconazole and potassium iodide should be agents of choice for treatment of subcutaneous sporotrichosis. However, treatment is controversial both in choice of agent used and in duration of therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714071

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  4 in total

1.  In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine.

Authors:  Lidiane Meire Kohler; Paulo César Fialho Monteiro; Rosane Christine Hahn; Júnia Soares Hamdan
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Evaluation of the origin of a sample of Sporothrix schenckii that caused contamination of a researcher in Southern Brazil.

Authors:  Melissa Fontes Landell; Cheila Denise Ottonelli Stopiglia; Raisa G Billodre; Daiane Heidrich; Julia Medeiros Sorrentino; Marilene H Vainstein; Maria Lúcia Scroferneker; Patricia Valente
Journal:  Mycopathologia       Date:  2010-09-12       Impact factor: 2.574

Review 3.  Sporotrichosis successfully treated with terbinafine and potassium iodide: case report and review of the literature.

Authors:  Basak Coskun; Yunus Saral; Nusret Akpolat; Arzu Ataseven; Demet Ciçek
Journal:  Mycopathologia       Date:  2004-07       Impact factor: 3.785

4.  Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis.

Authors:  Ana Raquel Mano Meinerz; Melissa O Xavier; Marlete Brum Cleff; Isabel Martins Madrid; Márcia Oliveira Nobre; Mário Carlos Araújo Meireles; João Roberto Braga de Mello
Journal:  Braz J Microbiol       Date:  2008-12-01       Impact factor: 2.476

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.